NASDAQ:ADAP

Adaptimmune Therapeutics plc

Stock

0.28 −0.58%

0.22

USD last updated 22/08 01:43:23

Last Close

0.06

21/08 22:30

Market Cap

293.91M

Beta: 2.24

Volume Today

564.86K

Avg: 683.17K

PE Ratio

−1.68

PFCF: −2.03

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Jun '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24
revenue		14.20M -	37.83M 166.47%	59.51M 57.28%	1.12M 98.11%	3.96M 252.76%	6.15M 55.36%	27.15M 341.50%	60.51M 122.91%	178.03M 194.20%
cost of revenue									9.86M -	70K 99.29%
gross profit		14.20M -	37.83M 166.47%	59.51M 57.28%	1.12M 98.11%	3.96M 252.76%	6.15M 55.36%	27.15M 341.50%	50.66M 86.60%	177.96M 251.30%
selling and marketing expenses									-25.99M -	506K 101.95%
general and administrative expenses		23.21M -	31.11M 34.03%	43.60M 40.17%	43.39M 0.48%	45.80M 5.54%	57.30M 25.13%	63.39M 10.61%	71.81M 13.29%	80.81M 12.53%
selling general and administrative expenses		23.21M -	31.11M 34.03%	43.60M 40.17%	43.39M 0.48%	45.80M 5.54%	57.30M 25.13%	63.39M 10.61%	45.82M 27.71%	81.31M 77.45%
research and development expenses		63.79M -	87.39M 37.00%	98.27M 12.45%	97.50M 0.78%	91.57M 6.09%	111.09M 21.32%	127.73M 14.98%	142.60M 11.65%	149.06M 4.53%
other expenses	-726.50K -	1.00M 237.92%	8.74M 772.65%	-15.50M 277.28%	75K 100.48%	1.16M 1,449.33%	3.85M 231.50%	-536K 113.91%	-807K 50.56%	16.35M 2,126.15%
cost and expenses		87.00M -	118.49M 36.20%	141.87M 19.73%	140.89M 0.69%	137.36M 2.50%	168.40M 22.59%	191.11M 13.49%	198.28M 3.75%	246.79M 24.47%
operating expenses	33.79M -	87.00M 157.46%	118.49M 36.20%	141.87M 19.73%	140.89M 0.69%	137.36M 2.50%	168.40M 22.59%	191.11M 13.49%	188.42M 1.41%	246.72M 30.94%
interest expense	-508.24K -		2.23M -	376K 83.14%				-1.01M -		3.35M -
ebitda		-69.51M -	-75.24M 8.24%	-74.56M 0.91%	-131.76M 76.73%	-125.81M 4.52%	-155.68M 23.74%	-157.89M 1.42%	-127.91M 18.99%	-52.66M 58.83%
operating income		-72.80M -	-80.66M 10.80%	-82.36M 2.11%	-139.77M 69.70%	-133.41M 4.55%	-162.25M 21.62%	-163.97M 1.06%	-137.77M 15.98%	-68.76M 50.09%
depreciation and amortization		3.29M -	5.42M 65.03%	7.81M 44.02%	8.01M 2.56%	7.59M 5.19%	6.57M 13.52%	6.08M 7.49%	9.86M 62.26%	11.23M 13.93%
total other income expenses net		1.00M -	8.74M 772.65%	-15.50M 277.28%	2.85M 118.37%	3.48M 22.06%	4.95M 42.36%	1.01M 79.66%	9.19M 813.77%	1.52M 83.44%
income before tax		-70.69M -	-69.69M 1.41%	-95.02M 36.35%	-136.92M 44.10%	-129.93M 5.11%	-157.30M 21.06%	-162.96M 3.60%	-128.57M 21.10%	-67.24M 47.70%
income tax expense		892K -	451K 49.44%	497K 10.20%	242K 51.31%	162K 33.06%	791K 388.27%	2.50M 215.68%	-14.26M 671.13%	3.58M 125.08%
net income	-21.59M -	-71.58M 231.56%	-70.14M 2.01%	-95.51M 36.18%	-137.16M 43.61%	-130.09M 5.16%	-158.09M 21.52%	-165.46M 4.66%	-114.31M 30.91%	-70.81M 38.05%
weighted average shs out	35.78M -	70.79M 97.81%	87.94M 24.23%	97.39M 10.75%	104.97M 7.78%	142.46M 35.72%	155.81M 9.36%	161.21M 3.47%	201.07M 24.73%	252.30M 25.48%
weighted average shs out dil	35.78M -	70.79M 97.81%	87.94M 24.23%	97.39M 10.75%	104.97M 7.78%	142.46M 35.72%	155.81M 9.36%	161.21M 3.47%	201.07M 24.73%	252.30M 25.48%
eps	-0.60 -	-1.01 68.33%	-0.80 20.79%	-0.98 22.50%	-1.31 33.67%	-0.91 30.53%	-1.01 10.99%	-1.03 1.98%	-0.57 44.66%	-0.28 50.88%
epsdiluted	-0.60 -	-1.01 68.33%	-0.80 20.79%	-0.98 22.50%	-1.31 33.67%	-0.91 30.53%	-1.01 10.99%	-1.03 1.98%	-0.57 44.66%	-0.28 50.88%

All numbers in USD (except ratios and percentages)